A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1

Recruiting

Phase 2

INTERCEPT RBCsA Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1

Sponsor:

Cerus Corporation

Code:

NCT07015437

Conditions

Healthy Subjects

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

INTERCEPT Blood System for RBCs

Infusion of autologous radiolabeled RBCs

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-26. This information was provided to ClinicalTrials.gov by Cerus Corporation on 2025-10-15.